- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 7/08 - Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Patent holdings for IPC class A61P 7/08
Total number of patents in this class: 316
10-year publication summary
|
13
|
18
|
20
|
20
|
17
|
24
|
29
|
15
|
25
|
8
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gambro Lundia AB | 1383 |
15 |
| Fresenius Medical Care Deutschland GmbH | 2100 |
11 |
| Sequana Medical NV | 51 |
10 |
| Terumo Kabushiki Kaisha | 5216 |
9 |
| TOMITA Pharmaceutical Co., Ltd. | 68 |
9 |
| Virtech bio, Inc. | 11 |
7 |
| Ajinomoto Co., Inc. | 2337 |
6 |
| Agios Pharmaceuticals, Inc | 200 |
5 |
| Cheer Global Ltd. | 10 |
5 |
| Kaneka Corporation | 4445 |
4 |
| Baxter International Inc. | 2425 |
4 |
| Baxter Healthcare S.A. | 1810 |
4 |
| Baylor University | 313 |
4 |
| National University Corporation Kagawa University | 213 |
4 |
| Omeros Corporation | 286 |
4 |
| Otsuka Pharmaceutical Factory, Inc. | 301 |
4 |
| Fuso Pharmaceutical Industries, Ltd. | 136 |
3 |
| Universitat de les Illes Balears | 74 |
3 |
| Corequest Sagl | 8 |
3 |
| Billion King International Limited | 4 |
3 |
| Other owners | 199 |